• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[沙门氏菌肠炎的合理治疗]

[Rational therapy of salmonella enteritis].

作者信息

Hof H, Kretschmar M

机构信息

Institut für Med. Mikrobiologie und Hygiene, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg.

出版信息

Leber Magen Darm. 1994 Mar;24(2):57-8, 61-4.

PMID:8196466
Abstract

One prerequisite for an effective treatment of a salmonella enteritis with antibiotics is a reliable direct antibacterial activity of the drug. In comparison to most of all other usual antibiotics quinolones, especially ciprofloxacin, fulfill these conditions, because its activity is high and resistance of Salmonella against quinolones is extremely rare. Since quinolone resistance is never plasmid coded, there will be even in the future no obvious risk of spreading of resistant strains. Another prerequisite is that the drug is able to have access to the site of residence of the microorganism. Salmonella spp. possess the virtue to penetrate into host cells and to reside and even to multiply there. Curing can be achieved only when these intracellular bacteria are eradicated. Elimination of Salmonella in the gut lumen alone is not satisfactory. Only few antibiotics are taken up into host cells, which could explain the rather frequent failure rate of antibiotic therapy of salmonella enteritis. Quinolones on the other hand are accumulated in host cells and in addition are able to act upon bacteria in this peculiar intracellular environment. Among the various quinolone derivatives ciprofloxacin is particularly qualified because it is excreted via the intestine to a considerable extent, so that high concentrations may be achieved at the proper site. The clinical experience demonstrates indeed that in most instances a rapid amelioration of the acute disease is achieved and in chronic carriers a high rate of curing occurs. Thus, for microbiological, pharmacological, and clinical reasons one can recommend ciprofloxacin for the treatment of enteric infections with Salmonella spp.

摘要

用抗生素有效治疗沙门氏菌肠炎的一个前提条件是药物具有可靠的直接抗菌活性。与大多数其他常用抗生素相比,喹诺酮类药物,尤其是环丙沙星,满足这些条件,因为其活性高,沙门氏菌对喹诺酮类药物的耐药性极为罕见。由于喹诺酮类耐药性从不由质粒编码,即使在未来也不会有耐药菌株传播的明显风险。另一个前提条件是药物能够到达微生物的驻留部位。沙门氏菌属具有侵入宿主细胞并在其中驻留甚至繁殖的特性。只有根除这些细胞内细菌才能实现治愈。仅消除肠道腔内的沙门氏菌并不令人满意。只有少数抗生素能进入宿主细胞,这可以解释沙门氏菌肠炎抗生素治疗失败率相当高的原因。另一方面,喹诺酮类药物在宿主细胞中蓄积,此外还能在这种特殊的细胞内环境中作用于细菌。在各种喹诺酮衍生物中,环丙沙星特别适用,因为它在很大程度上通过肠道排泄,因此在合适的部位可以达到高浓度。临床经验确实表明,在大多数情况下,急性疾病能迅速改善,慢性携带者的治愈率也很高。因此,出于微生物学、药理学和临床原因,对于沙门氏菌属引起的肠道感染,可推荐使用环丙沙星进行治疗。

相似文献

1
[Rational therapy of salmonella enteritis].[沙门氏菌肠炎的合理治疗]
Leber Magen Darm. 1994 Mar;24(2):57-8, 61-4.
2
[Excess mortality associated with antibiotic resistant Salmonella typhimurium].[与抗生素耐药性鼠伤寒沙门氏菌相关的超额死亡率]
Ugeskr Laeger. 2003 Jan 13;165(3):235-9.
3
[Reduction of the duration of salmonella excretion in infants with Hylak forte].[使用强力Hylak缩短婴儿沙门氏菌排泄持续时间的研究]
Padiatr Padol. 1991;26(2):111-4.
4
[The effectiveness of antibiotic treatment for Salmonella enteritis and Salmonella excretors].[抗生素治疗肠炎沙门氏菌及沙门氏菌排泄者的有效性]
Dtsch Med Wochenschr. 1977 Nov 25;102(47):1720-3. doi: 10.1055/s-0028-1105564.
5
Quinolones in the treatment of Salmonella carriers.
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1179-87. doi: 10.1093/clinids/11.supplement_5.s1179.
6
[Therapy of salmonella carriers].[沙门氏菌携带者的治疗]
Offentl Gesundheitswes. 1984 Sep;46(9):439-44.
7
[Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].T-3262(托氟沙星 tosylate)治疗沙门氏菌肠炎的临床试验以及急性腹泻患者粪便药物浓度和粪便微生物群变化。日本 T-3262 研究委员会,急性感染性肠炎研究组
Kansenshogaku Zasshi. 1989 Jul;63(7):659-75. doi: 10.11150/kansenshogakuzasshi1970.63.659.
8
[Rational antibiotic therapy of intestinal infections].
Vrach Delo. 1980 Mar(3):115-8.
9
[Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].[在一家儿科病房分离出的产超广谱β-内酰胺酶鼠伤寒沙门氏菌菌株的分型]
Sante. 1999 Nov-Dec;9(6):341-4.
10
Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica.环丙沙星和恩诺沙星对肠炎沙门氏菌的突变预防浓度。
J Antimicrob Chemother. 2004 Sep;54(3):688-91. doi: 10.1093/jac/dkh360. Epub 2004 Jul 8.